Yossi Cohen

3.3k total citations
63 papers, 2.2k citations indexed

About

Yossi Cohen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Yossi Cohen has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Pathology and Forensic Medicine and 12 papers in Hematology. Recurrent topics in Yossi Cohen's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (8 papers). Yossi Cohen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (8 papers). Yossi Cohen collaborates with scholars based in Israel, United States and Germany. Yossi Cohen's co-authors include Nadav Shashar, Yossi Loya, Michael Kühl, Bo Barker Jørgensen, Tage Dalsgaard, Niels Peter Revsbech, Aaron Polliack, Gail Amir, Nael Da’as and Nechemia Sar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yossi Cohen

59 papers receiving 2.1k citations

Peers

Countries citing papers authored by Yossi Cohen

Since Specialization

Citations

This map shows the geographic impact of Yossi Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yossi Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yossi Cohen more than expected).

Fields of papers citing papers by Yossi Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yossi Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yossi Cohen. The network helps show where Yossi Cohen may publish in the future.

Co-authorship network of co-authors of Yossi Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Yossi Cohen. A scholar is included among the top collaborators of Yossi Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yossi Cohen. Yossi Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unbalanced predatory communities and a lack of microbial degraders characterize the microbiota of a highly sewage-polluted Eastern-Mediterranean stream 2024 ·FEMS Microbiology Ecology ·Yossi Cohen, (unknown), (unknown), Zohar Pasternak, Antonis Chatzinotas, Édouard Jurkevitch	0
2	Clinical presentations and complications of lichen sclerosus: A systematic review 2024 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·(unknown), Suziyani Mohamed, Yossi Cohen, (unknown), (unknown), (unknown), (unknown), (unknown), Ivan V. Litvinov, Ilya Mukovozov	3
3	Community and single cell analyses reveal complex predatory interactions between bacteria in high diversity systems 2021 ·Nature Communications ·Yossi Cohen, Zohar Pasternak, Susann Müller, Thomas Hübschmann, Florian Schattenberg, (unknown), (unknown), Antonis Chatzinotas, Édouard Jurkevitch	28
4	782-P: Personalized, Machine Learning-Based Nutrition Reduces Diabetes Markers in Type 2 Diabetic Patients 2019 ·Diabetes ·(unknown), (unknown), Tali Raveh-Sadka, Yossi Cohen, (unknown)	0
5	Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome 2018 ·Leukemia Research ·Chezi Ganzel, Ory Rouvio, Irit Avivi, Hila Magen, (unknown), (unknown), Yossi Cohen, Tamar Tadmor, (unknown), Merav Leiba, Arnon Nagler, Yaël C. Cohen, Shlomo Bulvik, Aaron Polliack, Jacob M. Rowe, Moshe E. Gatt	10
6	A New Comparative-Genomics Approach for Defining Phenotype-Specific Indicators Reveals Specific Genetic Markers in Predatory Bacteria 2015 ·PLoS ONE ·Zohar Pasternak, (unknown), Yossi Cohen, Elad Segev, Édouard Jurkevitch	5
7	Multiple micro-predators controlling bacterial communities in the environment 2014 ·Current Opinion in Biotechnology ·(unknown), Yossi Cohen, (unknown), Ariel Kushmaro, Édouard Jurkevitch, Antonis Chatzinotas	72
8	Niche-modulated and niche-modulating genes in bone marrow cells 2012 ·Blood Cancer Journal ·Yossi Cohen, (unknown), Adina Bar‐Chaim, Abraham Kornberg	5
9	The increased expression of 14q32 small nucleolar RNA transcripts in promyelocytic leukemia cells is not dependent on PML–RARA fusion gene 2012 ·Blood Cancer Journal ·Yossi Cohen, Keith P. Hertzog, Orit Reish, (unknown), (unknown), Adina Bar‐Chaim, L. Trakhtenbrot, Abraham Kornberg	9
10	Activation of Relaxin‐Related Receptors by Short, Linear Peptides Derived from a Collagen‐Containing Precursor 2009 ·Annals of the New York Academy of Sciences ·Ronen Shemesh, (unknown), Amir Toporik, Zurit Levine, Amit Novik, (unknown), Yossef Kliger, Avi Z. Rosenberg, Ross A. D. Bathgate, Yossi Cohen	14
11	A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Iris Hecht, Rong Jiang, André Luiz Franco Sampaio, (unknown), (unknown), Ronen Shemesh, Amir Toporik, (unknown), (unknown), Hagit Niv, Gady Cojocaru, (unknown), Galit Rotman, Mauro Perretti, Jakob Vinten‐Johansen, Yossi Cohen	49
12	Discovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors 2008 ·Journal of Biological Chemistry ·Ronen Shemesh, Amir Toporik, Zurit Levine, Iris Hecht, Galit Rotman, (unknown), Dvir Dahary, (unknown), (unknown), (unknown), Avi Z. Rosenberg, Dani Eshel, Yossi Cohen	62
13	A lectin array-based methodology for the analysis of protein glycosylation 2006 ·Journal of Biochemical and Biophysical Methods ·Rakefet Rosenfeld, (unknown), Gerrit J. Gerwig, (unknown), (unknown), Yossi Cohen, Yehudit Amor, Inbar Plaschkes, Johannis P. Kamerling, Ruth Maya	78
14	Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients 2005 ·Diabetic Medicine ·Julio Wainstein, Muriel Metzger, Mona Boaz, Oscar Minuchin, Yossi Cohen, (unknown), (unknown), Itamar Raz, Ilana Harman‐Boehm	105
15	Rapidly progressive diffuse large B‐cell lymphoma with initial clinical presentation mimicking seronegative Wegener's granulomatosis 2004 ·European Journal Of Haematology ·Yossi Cohen, Gail Amir, (unknown), Ninette Amariglio, Aaron Polliack	11
16	Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support 2003 ·Current Pharmaceutical Design ·Yossi Cohen, Aaron Polliack, Arnon Nagler	16
17	Unusual cytomegalovirus complications after autologous stem cell transplantation for large B cell lymphoma: massive gastrointestinal hemorrhage followed by a communicating hydrocephalus 2002 ·Bone Marrow Transplantation ·Yossi Cohen, Ora Paltiel, G Amir, (unknown), Dan Engelhard, Aaron Polliack	1
18	Development and rapid dissemination of Merkel‐cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma 2002 ·European Journal Of Haematology ·Yossi Cohen, Gail Amir, Aaron Polliack	13
19	Neurotoxicity with Leukoencephalopathy after a Single Intravenous High Dose of Methotrexate in a Patient with Lymphoma 2002 ·Acta Haematologica ·Yossi Cohen, (unknown), Aaron Polliack	3
20	[Pharmacokinetics of DL-norephedrine 14C in the rat]. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), (unknown), Yossi Cohen	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact